Pharmaceutical Stocks

TXMD Stock – TherapeuticsMD Shares Surge on Vaginal Study Results

TherapeuticsMD said that two studies found positive results for its new Vulvar Vaginal Atrophy drug, sending TXMD stock up in Tuesday trading. More 

NWBO Stock – Northwest Biotherapeutics Jumps on Expansion News

Northwest Biotherapeutics says it has made a deal with its contract manufacturer to expand production and testing infrastructure, sending NWBO stock higher. More 

GERN Stock – Geron Shares Sink on Drug Study News

Regulatory filings that indicated that a study of a Geron drug had stopped accepting new patients sent GERN stock down sharply in Monday trading. More 

MRK: Merck Stock a Strong Performer In the Pharma Space

Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More 

PTCT Stock – PTC Therapeutics Plummets on Muscular Dystrophy Drug News

PTC Therapeutics announced that a European regulatory has taken a negative opinion of its muscular dystrophy drug, sending PTCT stock down sharply. More 

BDSI Stock – New Chronic Pain Drug Sends BioDelivery Soaring

Good results from a late-stage trial for a drug from BioDelivery Sciences sent BDSI stock surging in Friday trading. More 

Under Obamacare, Risks Grow for High-Margin Drug Stocks

The implementation of Obamacare means that reimbursement rates for certain drugs will be cut. Here's what that means for drug stocks like Questcor. More 

AMAG Stock – Amag Shares Sink as FDA Rejects Wider Use of Anemia Drug

Amag Pharmaceutical announced that the FDA has refused to approve wider use of Feraheme, sending AMAG stock down sharply. More 

SRPT Stock – Sarepta Shares Up on Muscular Dystrophy Drug Success

Sarepta Therapeutics released more data for its muscular dystrophy drugs, showing continued patient improvement, sending SRPT stock sharply higher. More 

CHTP Stock – Chelsea Therapeutics Passes FDA Test, Stock Skyrockets

An FDA advisory panel reportedly voted to support a drug from Chelsea Therapeutics, sending CHTP stock soaring. More